BhowmikD., MahajanS., BoraM.Concerns regarding the ISPD guidelines/recommendations for peritonitis due to mycobacteria.Perit Dial Int2011; 31: 363–364.
ChowK.M., ChowV.C., HungL.C., WongS.M., SzetoC.C.Tuberculous peritonitis–associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples.Clin Infect Dis2002; 35: 409–13.
4.
AhnC., OhK.H., KimK., LeeK.Y., LeeJ.G., OhM.D.Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampin.Perit Dial Int2003; 23: 362–7.
MoriwakiK., KannoY., NakamotoH., OkadaH., SuzukiH.Vitamin B6 deficiency in elderly patients on chronic peritoneal dialysis.Adv Perit Dial2000; 16: 308–12.
7.
British Medical Association (BMA), Royal Pharmaceutical Society of Great Britain (RPSGB).British National Formulary.59th ed.London, UK: BMA and RPSGB; 2010: 592.
8.
MalikG.H., Al-HarbiA.S., Al-MohayaS., Al-KhawajahH., KechridM., Al HassanA.O.Eleven years of experience with dialysis associated tuberculosis.Clin Nephrol2002; 58: 356–62.
9.
LuiS.L., TangS., LiF.K., ChoyB.Y., ChanT.M., LoW.K.Tuberculosis infection in Chinese patients undergoing continuous ambulatory peritoneal dialysis.Am J Kidney Dis2001; 38: 1055–60.
